NCT07221838 2026-03-03
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4 Not yet recruiting
Clinical Trials
3 trialsNCT07365995 2026-01-26
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
BioNTech SE
Phase 3 Not yet recruiting
NCT06099990 2023-10-25
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Not yet recruiting